Eric D. Shaff, CEO and President: Seres Therapeutics MCRB Sell · Filed 24/05/17

Trade details

Type: Insider sale
Amount: $2,288.9
Shares · price: 2,435 sh · $0.94 a share
Held after: 140,698 sh
Stock: Seres Therapeutics MCRB
Person: Eric D. ShaffCEO and President
Trade date: 24/05/15
Filed: 24/05/17
Days to filing: 2 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/15~24/06/14

Eric D. Shaff's recent trades

Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,950
259 sh
$1,950
Filed 05/19
Traded 05/18
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$2,194
259 sh
$2,194
Filed 02/18
Traded 02/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,754
217 sh
$3,754
Filed 25/11/18
Traded 25/11/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,613
217 sh
$3,613
Filed 25/08/19
Traded 25/08/18
Eric D. ShaffCEO and President
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,602
220 sh
$1,602
Filed 25/05/19
Traded 25/05/16